Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma

Junyu Huo; Liqun Wu; Yunjin Zang

doi:10.12659/MSM.925494

18 September 2020 : Database Analysis

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma

Junyu Huo^1ABCDEF, Liqun Wu^1AEF*, Yunjin Zang^1AE

DOI: 10.12659/MSM.925494

Med Sci Monit 2020; 26:e925494

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 Internal validation of the prognostic model in the TCGA cohort according to clinical features. (A) AFP. (B) Age. (C) BMI. (D) Family cancer history. (E) Gender. (F) Tumor status. (G) New tumor event after treatment initiation. (H) Prior malignancy. (I) Histologic grade. (J) AJCC stage. (K) Vascular tumor cell type. (L) Race.

Back to the Article

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma

Your Privacy